Meghmani Organics Limited · NSE:MOL

Meghmani Organics — Q4 FY2021 Earnings Presentation

36 slides from Meghmani Organics's earnings presentation, May 24, 2021

  1. Slide 1: Cover letter to stock exchanges

    May 24, 2021 To, National Stock Exchange of India BSE Limited Limited Floor- 25, P J Tower, “Exchange Plaza”, Dalal Street, Bandra-Kurla Complex, Mumbai 400 00 Bandra (East) Mumbai 400 051 Sub:- Investor Presentation on the Financials for the quarter and year ended 31° March, 2021 of Meghmani Organo

  2. Slide 2: Q4 & FY21 Results Presentation

    Meghmani Organochem Limited Erstwhile Meghmani Organics Limited (MOL) Q4 & FY21 Results Presentation May 2021

  3. Slide 3: Disclaimer

    Disclaimer The presentation has been prepared by Meghmani Organics Limited (“MOL” or the “Company”) solely for information purposes and does not constitute an offer to sell or, recommendation or solicitation of an offer to subscribe for or purchase any securities and nothing contained herein shall f

  4. Slide 4: Discussion Summary

    Discussion Summary Q4 & FY21 Results Update About Us Business Overview Strategy & Outlook Financial Overview Scheme of Arrangement 3

  5. Slide 5: From the Desk of CEO, Ankit Patel

    From the Desk of CEO, Ankit Patel Meghmani Organics continued to deliver modest results in FY21 despite lockdowns and curfew scenarios during the COVID-19 pandemic. The Company’s capacity utilization during the challenging times of FY21 stood at ~77% for the Pigment division and ~76% for the Agroche

  6. Slide 6: Impact of Scheme of Arrangement & One-off Items

    Impact of Scheme of Arrangement & One-off Items  Scheme of Arrangement (SOA) approved by NCLT on 3rd May 2021. The Agrochemicals and Pigment business has been demerged into Meghmani Organochem Ltd. (MOCL) with effect 15th Oct. 2019. Accordingly, the yearly reported financials in MOCL for FY20 are f

  7. Slide 7: Q4 & FY21 Results: Key Highlights

    Q4 & FY21 Results: Key Highlights Q4 & FY21 YoY Analysis Rs Mn Revenues & Gross Margin EBITDA & EBITDA Margin PAT & PAT Margin* 36.7% 39.4% 16.7% 13.1% 7.4% 7.7% 4,592 4,047 675 530 338 353 Q4 FY20 Q4 FY21 Q4 FY20 Q4 FY21 Q4 FY20 Q4 FY21 FY21 YoY Analysis 38.0% 44.7% 14.5% 17.2% 11.9% 11.4% 16,247 1

  8. Slide 8: Q4 & FY21 Results: Pigments Business

    Q4 & FY21 Results: Pigments Business Q4 FY21 YoY Analysis Rs Mn Production & Utilisation (%) Net Revenue (Rs Mn) & Exports* EBITDA (Rs Mn) & Margin (%) 76% 88% 83 % 78 % 600 9,000 13.9% 13.5% 8,000 7,300 50.0% 500 20.0% 1,900 7,000 6,240 0.0% 1,800 1,648 10.0% -50.0% 400 6,000 1,700 1,559 0.0% 1,600

  9. Slide 9: Q4 & FY21 Results: Agrochemicals Business

    Q4 & FY21 Results: Agrochemicals Business Q4 FY21 YoY Analysis Rs Mn Production & Utilisation (%) Net Revenue (Rs Mn) & Exports* EBITDA (Rs Mn) & Margin (%) 79 % 77 % 14,000 54% 81% 100.0% 1,200 30.0% 12,000 9,228 50.0% 4,000 1,000 14.6% 15.7% 20.0% 10,000 8,000 0.0% 3,500 2,993 800 10.0% 3,000 6,00

  10. Slide 10: Q4 & FY21 Results: Profit & Loss Statement

    Q4 & FY21 Results: Profit & Loss Statement Particulars (Rs. in Mn) Q4 FY21 Q4 FY20 YoY% FY21 FY20* YoY% Revenue from Operations 4,592 4,047 13.5% 16,234 16,247 -0.1% COGS 2,782 2,561 8.7% 8,975 10,067 -10.8% Gross Profit 1,810 1,487 21.7% 7,260 6,180 17.5% Gross Margins % 39.4% 36.7% 268 bps 44.7% 3

  11. Slide 11: Balance Sheet Statement

    Balance Sheet Statement Particulars (Rs. in Mn) Mar 21 *Mar 20 Particulars (Rs. in Mn) Mar 21 *Mar 20 Equity & Liabilities Assets Share Capital 254 254 Property, Plant & Equipment 6,286 4,646 Reserves & Surplus 11,418 9,654 Capital WIP 1,059 964 Shareholder's Funds 11,673 9,908 Intangible Assets 111

  12. Slide 12: About Us

    Discussion Summary Q4 & FY21 Results Update About Us Business Overview Strategy & Outlook Financial Overview Scheme of Arrangement 11

  13. Slide 13: Leading Diversified Chemicals Company Poised for Rapid Growth

    Leading Diversified Chemicals Company Poised for Rapid Growth Pigments Agrochemicals • Started in 1986 • Started in 1995 • Amongst top 3 global Phthalocyanine based pigment • Among Top 10 producers of pesticides in India players • Products across entire value chain • 14% global market share • FY21 R

  14. Slide 14: Sustainable Competitive Advantages

    Sustainable Competitive Advantages Experienced & Qualified Management Strong Financial Performance and Technical Team • Consistent Revenue Growth • Rich experience of many decades in chemical sector among the founding members of the • Improving Profitability & Return Ratios company • Healthy Balance

  15. Slide 15: Key Financial Metrics

    Key Financial Metrics Robust Return Ratios • Improving profitability • Strong & lean Balance Sheet Consistent Revenue Growth • Significant improvement in return ratios • Revenues have grown at CAGR 8.0% 01 04 • ROCE – 9.6% in FY17 to 16.1% in FY21 over FY17-21, with higher contribution • ROE – 6.8%

  16. Slide 16: Key Milestones

    Key Milestones  Commissioned 2 New Plants in Agro Division: - Doubling the capacity of 2,4-D to 21,600 TPA 2020 - 21 - New Formulation Plant  Setting up new Multipurpose Plant (New Molecules)  Scheme of Arrangement approved by NCLT. Independent listing of Chloro-Alkalies & Derivatives business to

  17. Slide 17: Business Overview

    Discussion Summary Q4 & FY21 Results Update About Us Business Overview Strategy & Outlook Financial Overview Scheme of Arrangement 16

  18. Slide 18: Pigments Business: Key Highlights

    Pigments Business: Key Highlights Established Business Profile Vertically Integrated Manufacturing Facilities • Largest manufacturers of Phthalocyanine-based pigments with Total Capacity – 33,180 TPA 14% global market share & amongst top 3 (capacity wise) global pigments players Location Capacity Pr

  19. Slide 19: Pigments Business: Operational Overview

    Pigments Business: Operational Overview Production (MT) Net Sales & Exports* (Rs Mn) 68 % 79 % 81 % 77 % 78 % 35,000 6,048 6,406 5,877 5,784 30,000 25,982 25,226 25,694 25,349 6,100 5,242 5,100 25,000 20,194 4,100 20,000 3,100 2,100 15,000 1,100 10,000 100 FY17 FY18 FY19 FY20 FY21 FY17 FY18 FY19 FY2

  20. Slide 20: Pigments Business: Industry Overview

    Pigments Business: Industry Overview Global Pigments Market Global Pigments Market Size (USD Bn) • The global pigments industry consists of three segments – organic, in-organic and specialty pigment 50.0 43.0 • Organic pigments account for 35-40% mkt. share out of total 45.0 40.0 29.0 35.0 pigments

  21. Slide 21: Agrochemicals Business: Key Highlights

    Agrochemicals Business: Key Highlights Established Business Profile Product Profile • Leading manufacturer of pesticides – products across entire value chain Used for captive consumption • Established global presence across Africa, Brazil, LatAm, US and Europe Pesticide Intermediates • Strong pan-In

  22. Slide 22: Agrochemicals Business: Operational Overview

    Agrochemicals Business: Operational Overview Registrations Base Production (MT) 30,000 27,898 646 680 581 567 616 25,000 18,431 18,666 18,145 370 20,000 16,219 348 356 354 307 15,000 10,000 260 268 290 310 5,000 227 0 FY17 FY18 FY19 FY20 FY21 FY17 FY18 FY19 FY20 FY21 Exports CIB (India) Net Sales an

  23. Slide 23: Agrochemicals Business: Crop-protection Industry Overview

    Agrochemicals Business: Crop-protection Industry Overview Global Crop Protection Market Global Crop Protection Market (USD Bn) • The global crop protection market is set to grow steadily to reach USD 59 Bn by 2020 58.7 • Key drivers - growing population, declining arable land & rising pest 51.2 1.7

  24. Slide 24: Strategy & Outlook

    Discussion Summary Q4 & FY21 Results Update About Us Business Overview Strategy & Outlook Financial Overview Scheme of Arrangement 23

  25. Slide 25: Roadmap for achieving 20% + top-line growth in next 3 years

    Roadmap for achieving 20% + top-line growth in next 3 years • Among Top 3 producer of phthalocyanine pigments globally • Continue to focus on increasing domestic presence and capture market share Pigments • Expanding into new geographies • Diversification into new pigments • The management eyes a re

  26. Slide 26: Agrochemicals: Capex Plan

    Agrochemicals: Capex Plan Capex Expected date of Expected Revenue Project (Rs mn) Completion (Rs mn) 2,4-D (Capacity – 10.8k 1,270 Commissioned 2,000 TPA) Formulation Plant 250 Commissioned 1,500 Multi Purpose Plant 3,100 Q1 FY23 6,000 (New Molecules) Total 4,620 9,500 25

  27. Slide 27: Financial Overview

    Discussion Summary Q4 & FY21 Results Update About Us Business Overview Strategy & Outlook Financial Overview Scheme of Arrangement 26

  28. Slide 28: Financial Snapshot

    Financial Snapshot Rs Mn Revenues & Gross Margin EBITDA & EBITDA Margin PAT & PAT Margin * CAGR 8% * CAGR 16% * CAGR 35% 11.4% 12.0% 11.9% 42.1% 42.5% 44.7% 17.2% 38.0% 16.5% 36.2% 13.6% 14.5% 6.2% 1,850 11.9% 1,921 2,799 4.0% 1,687 16,247 16,234 2,323 2,363 12,605 14,104 11,175 1,712 1,332 769 415

  29. Slide 29: Financial Snapshot

    Financial Snapshot Rs Mn Leverage Analysis Working Capital Analysis * 130 106 112 115 113 0.56 0.60 0.39 0.27 0.23 82 74 81 65 77 6,977 9,908 11,673 6,329 8,380 103 89 85 92 92 3,533 4,170 3,265 2,639 2,630 -55 -48 -50 -51 -60 FY17 FY18 FY19 FY20 FY21 FY17 FY18 FY19 FY20 FY21 Debt Equity D/E Receiva

  30. Slide 30: Scheme of Arrangement

    Discussion Summary Q4 & FY21 Results Update About Us Business Overview Strategy & Outlook Financial Overview Scheme of Arrangement 29

  31. Slide 31: Scheme of Arrangement

    Scheme of Arrangement MEGHMANI ORGANICS LTD (MOL) MEGHMANI FINECHEM LTD (MFL) Investment “Other Business” Agro in RPS* of Pigments (Trading + Equity Chlor Alkali & its Derivatives Chemicals MFL Investment in MFL) Demerger Amalgamation of “Other Business” of MOL with MFL Meghmani Organochem Ltd (WOS

  32. Slide 32: Rationale for Restructuring

    Rationale for Restructuring Objectives Value Unlocking Delisting from SGX  Aimed to position ‘Chloro  Unlocking value of the ‘Chloro  Shares (SDSs) issued by MOL Alkali and its Derivatives’ as Alkali and its Derivatives’ under depository mechanism independent and sustainable business on SGX will

  33. Slide 33: Share Capital Structure (MOL) Post Demerger

    Share Capital Structure (MOL) Post Demerger  There will not be any change in Shareholding pattern of MOL post demerger.  MOL shareholder’s will get 94 shares (FV Rs10) of MFL for every 1000 shares held in MOL (FV Rs 1). MOL Shareholding - Pre and Post Demerger Particulars No of shares (FV Rs 1 ) %

  34. Slide 34: Share Capital Structure (MOL) Post Demerger

    Share Capital Structure (MOL) Post Demerger MFL Shareholding Pre-Demerger New Shares to be issued by MFL as per Scheme Particulars No of Shares (FV10) % Total No of shares in MOL 254,314,211 MOL 23,545,985 57.16% Swap Ratio 0.94 Individual Promoters 17,647,129 42.84% New shares to be issued by MFL t

  35. Slide 35: Restructuring - Approvals & Indicative Timeline

    Restructuring - Approvals & Indicative Timeline Sr. No. Key Approvals Indicative Timelines 1 Prior approval of Singapore stock exchange and Securities Industries council In principle approval obtained 2 Receipt of observations/comments from Stock exchanges on the scheme and Securities Approval recei

  36. Slide 36: For Further Queries

    For Further Queries: Gurjant Singh Chahal, CFO Hiral Keniya / Vikash Verma, IR Consultants Email: ir@meghmani.com Phone: +91-79717 61000 Contact: 90296 62801 / 96640 09029 Email: meghmani@dickensonworld.com Bharat Mody, IR Advisor Email: ir@meghmani.com Contact:- 98980 46584

Meghmani Organics — Q4 FY2021 Earnings Presentation on 6ix